These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

575 related articles for article (PubMed ID: 25195550)

  • 1. Incidence of non-alcoholic fatty liver disease in Hong Kong: a population study with paired proton-magnetic resonance spectroscopy.
    Wong VW; Wong GL; Yeung DK; Lau TK; Chan CK; Chim AM; Abrigo JM; Chan RS; Woo J; Tse YK; Chu WC; Chan HL
    J Hepatol; 2015 Jan; 62(1):182-9. PubMed ID: 25195550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography.
    Wong VW; Chu WC; Wong GL; Chan RS; Chim AM; Ong A; Yeung DK; Yiu KK; Chu SH; Woo J; Chan FK; Chan HL
    Gut; 2012 Mar; 61(3):409-15. PubMed ID: 21846782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and Severity of Nonalcoholic Fatty Liver Disease in Non-Obese Patients: A Population Study Using Proton-Magnetic Resonance Spectroscopy.
    Wei JL; Leung JC; Loong TC; Wong GL; Yeung DK; Chan RS; Chan HL; Chim AM; Woo J; Chu WC; Wong VW
    Am J Gastroenterol; 2015 Sep; 110(9):1306-14; quiz 1315. PubMed ID: 26215532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the New Definition of Metabolic Associated Fatty Liver Disease on the Epidemiology of the Disease.
    Wong VW; Wong GL; Woo J; Abrigo JM; Chan CK; Shu SS; Leung JK; Chim AM; Kong AP; Lui GC; Chan HL; Chu WC
    Clin Gastroenterol Hepatol; 2021 Oct; 19(10):2161-2171.e5. PubMed ID: 33137486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Community-based lifestyle modification programme for non-alcoholic fatty liver disease: a randomized controlled trial.
    Wong VW; Chan RS; Wong GL; Cheung BH; Chu WC; Yeung DK; Chim AM; Lai JW; Li LS; Sea MM; Chan FK; Sung JJ; Woo J; Chan HL
    J Hepatol; 2013 Sep; 59(3):536-42. PubMed ID: 23623998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacterial endotoxin and non-alcoholic fatty liver disease in the general population: a prospective cohort study.
    Wong VW; Wong GL; Chan HY; Yeung DK; Chan RS; Chim AM; Chan CK; Tse YK; Woo J; Chu WC; Chan HL
    Aliment Pharmacol Ther; 2015 Sep; 42(6):731-40. PubMed ID: 26202818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of prevalent but not incident non-alcoholic fatty liver disease by levels of serum testosterone.
    Seo NK; Koo HS; Haam JH; Kim HY; Kim MJ; Park KC; Park KS; Kim YS
    J Gastroenterol Hepatol; 2015 Jul; 30(7):1211-6. PubMed ID: 25708291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of water-fat MRI and proton MRS in assessment of hepatic fat and the heterogeneous distribution of hepatic fat and iron in subjects with non-alcoholic fatty liver disease.
    Hui SCN; So HK; Chan DFY; Wong SKH; Yeung DKW; Ng EKW; Chu WCW
    Eur J Radiol; 2018 Oct; 107():7-13. PubMed ID: 30292275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-high-density lipoprotein cholesterol independently predicts new onset of non-alcoholic fatty liver disease.
    Zelber-Sagi S; Salomone F; Yeshua H; Lotan R; Webb M; Halpern Z; Santo E; Oren R; Shibolet O
    Liver Int; 2014 Jul; 34(6):e128-35. PubMed ID: 24118857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cohort study of non-alcoholic fatty liver disease, NAFLD fibrosis score, and the risk of incident diabetes in a Korean population.
    Chang Y; Jung HS; Yun KE; Cho J; Cho YK; Ryu S
    Am J Gastroenterol; 2013 Dec; 108(12):1861-8. PubMed ID: 24100261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B virus infection and fatty liver in the general population.
    Wong VW; Wong GL; Chu WC; Chim AM; Ong A; Yeung DK; Yiu KK; Chu SH; Chan HY; Woo J; Chan FK; Chan HL
    J Hepatol; 2012 Mar; 56(3):533-40. PubMed ID: 22027575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrahepatic triglyceride content is independently associated with chronic kidney disease in obese adults: A cross-sectional study.
    Pan LL; Zhang HJ; Huang ZF; Sun Q; Chen Z; Li ZB; Yang SY; Li XY; Li XJ
    Metabolism; 2015 Sep; 64(9):1077-85. PubMed ID: 26144271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histologically proven non-alcoholic fatty liver disease and clinically related factors in recipients after liver transplantation.
    Kim H; Lee K; Lee KW; Yi NJ; Lee HW; Hong G; Choi Y; You T; Suh SW; Jang JJ; Suh KS
    Clin Transplant; 2014 May; 28(5):521-9. PubMed ID: 24579874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk for the development of non-alcoholic fatty liver disease: A prospective study.
    Wang J; Ma L; Chen S; Xu L; Miao M; Yu C; Li Y; Xu C
    J Gastroenterol Hepatol; 2018 Aug; 33(8):1518-1523. PubMed ID: 29381226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-invasive screening of diabetics in primary care for NAFLD and advanced fibrosis by MRI and MRE.
    Doycheva I; Cui J; Nguyen P; Costa EA; Hooker J; Hofflich H; Bettencourt R; Brouha S; Sirlin CB; Loomba R
    Aliment Pharmacol Ther; 2016 Jan; 43(1):83-95. PubMed ID: 26369383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Change in hepatic fat content measured by MRI does not predict treatment-induced histological improvement of steatohepatitis.
    Bril F; Barb D; Lomonaco R; Lai J; Cusi K
    J Hepatol; 2020 Mar; 72(3):401-410. PubMed ID: 31589891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced liver fibrosis predicts heart failure and hospitalizations in people with type 2 diabetes: A prospective cohort study from Hong Kong Diabetes Register.
    Kong AP; Lau ES; O CK; Luk AO; Yip TC; Chow EY; Kwok R; Lee HW; Wong GL; Ma RC; Chan HL; Wong VW; Chan JC
    Diabetes Res Clin Pract; 2023 Aug; 202():110825. PubMed ID: 37442241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-alcoholic fatty liver disease independently predicts prediabetes during a 7-year prospective follow-up.
    Zelber-Sagi S; Lotan R; Shibolet O; Webb M; Buch A; Nitzan-Kaluski D; Halpern Z; Santo E; Oren R
    Liver Int; 2013 Oct; 33(9):1406-12. PubMed ID: 23656177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-alcoholic fatty liver disease: spectral patterns observed from an in vivo phosphorus magnetic resonance spectroscopy study.
    Abrigo JM; Shen J; Wong VW; Yeung DK; Wong GL; Chim AM; Chan AW; Choi PC; Chan FK; Chan HL; Chu WC
    J Hepatol; 2014 Apr; 60(4):809-15. PubMed ID: 24291241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic and histological implications of intrahepatic triglyceride content in nonalcoholic fatty liver disease.
    Bril F; Barb D; Portillo-Sanchez P; Biernacki D; Lomonaco R; Suman A; Weber MH; Budd JT; Lupi ME; Cusi K
    Hepatology; 2017 Apr; 65(4):1132-1144. PubMed ID: 27981615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.